Autres langues GuiZhou SanLi Pharmaceutical Co.,Ltd

Actions

603439

CNE1000040B4

Produits pharmaceutiques

Cours en clôture Shanghai S.E. 14/08/2026			Varia. 5j.	Varia. 1 janv.
13,53 ^CNY	+4,64%		+20,91%	+15,64%

26/05	Guizhou Sanli Pharmaceutical va lever jusqu'à 700 millions de yuans via un placement privé	MT
25/05	Guizhou Sanli Pharmaceutical va lever des fonds via un placement privé	RE

Autres langues

26/05	Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement
25/05	Guizhou Sanli pharmaceutical to raise funds via private placement
25/05	Guizhou Sanli Pharmaceutical Co.,Ltd announced that it expects to receive CNY 700 million in funding
27/04	Guizhou Sanli Pharmaceutical Co.,Ltd announces Annual dividend, payable on June 30, 2026
26/04	Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2025
26/04	Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026
23/04	Guizhou Sanli Pharmaceutical Co.,Ltd announced that it expects to receive CNY 300 million in funding
03/12	Sanli Pharma to Withdraw Stake in Associate; Shares Down 3%
27/10/25	Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025
12/09/25	Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on September 13, 2024.
11/09/25	Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback announced on September 12, 2024, has closed with 7,869,300 shares, representing 1.93% for CNY 99.95 million.
27/08/25	Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2025
23/04/25	Guizhou Sanli Pharmaceutical Co.,Ltd announces Annual dividend, payable on June 26, 2025
22/04/25	Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2025
22/04/25	Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2024
04/04/25	Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on September 13, 2024.
03/01/25	Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on September 13, 2024.
20/12/24	Guizhou Sanli Pharmaceutical Co.,Ltd completed the acquisition of additional 22.91% stake in Guizhou Hanfang Pharmaceutical Co., Ltd. from Deng Daixing.
04/12/24	Guizhou Sanli Pharmaceutical Co.,Ltd agreed to acquire an additional 22.91% stake in Guizhou Hanfang Pharmaceutical Co., Ltd. from Deng Daixing for approximately CNY 170 million
28/10/24	Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2024
09/10/24	Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on September 13, 2024.
20/09/24	Guizhou Sanli Pharmaceutical Co.,Ltd agreed to acquire an additional 40% stake in Guizhou Sankang Enterprise Management Partnership Enterprise (Limited Partnership) from Guizhou Health Agriculture Chinese Medicine Food Material Development Group Co., Ltd. for CNY 40 million.
13/09/24	Guizhou Sanli Pharmaceutical Plans Up to 120-Million-Yuan Share Buyback
13/09/24	Guizhou Sanli Pharmaceutical Co.,Ltd announces an Equity Buyback for CNY 120 million worth of its shares.
12/09/24	Guizhou Sanli Pharmaceutical Co.,Ltd authorizes a Buyback Plan.